KUALA LUMPUR, Tuesday, 7th May – Kotra Pharma (M) Sdn. Bhd. (Kotra Pharma), the wholly-owned subsidiary of Kotra Industries Bhd., was recently awarded the inaugural Industry Excellence Award by the Malaysian National Pharmaceutical Control Bureau (NPCB).
This award conferred upon Kotra Pharma was in recognition of the company’s track record for its Good Manufacturing Practices (GMP), which are compliant with internationally recognised standards.
“It was an honour and a pleasant surprise to receive the Industry Excellence Award from NPCB. To us at Kotra Pharma, it signified a positive milestone in our journey to become the centre of excellence for the pharmaceutical industry. It is akin to a nod of recognition by our Malaysian government and to ourselves that we are on the correct path and that our investment of time, efforts and finances has all been worthwhile” said Jimmy Piong, Managing Director of Kotra Pharma.
Kotra Pharma is a million dollar manufacturing company headquartered in Malaysia, focusing on the research and development of prescription drugs and healthcare supplements. To date Kotra Pharma has a strong global presence in 30 countries worldwide and has invested over USD50million in a new state-of-the-art manufacturing and research facility, which constitutes the largest single-investment on a single location in the history of the Malaysian pharmaceutical industry to date.
As one of the major local pharmaceutical companies and a trail-blazer in the Malaysian pharmaceutical industry, Kotra Pharma in its 30 years has continuously evolved and grown into an internationally recognised brand that has also been acknowledged as the Malaysian Pharmaceutical Company of the year – Best Practices Award by Frost and Sullivan in 2011.
“In this competitive market, we are grateful to be where we are today. We are still very much a young company and accept that we still have a long way ahead of us if we are to achieve our mission to be the centre of excellence for the pharmaceutical industry. We look forward to this journey and continuously challenge ourselves to further expand our annals of achievements. Having said that, we strongly believe and have the conviction to realise both our mission to be the centre of excellence for the pharmaceutical industry and our vision of Humanising Health as we believe everyone deserves a healthier tomorrow” concluded Jimmy Piong.
The Industry Excellence Award is judged based on a company’s GMP track record. It is part of the government’s initiative to drive export of pharmaceuticals overseas and improve the standards of the pharmaceutical industry within Malaysia.
About Kotra Pharma (M) Sdn. Bhd.
Kotra Industries Berhad, via its wholly owned subsidiary, Kotra Pharma (M) Sdn Bhd, engages in the development, manufacturing and trade of pharmaceutical and healthcare products in Malaysia and internationally. The company manufactures a wide range of over-the-counter and prescriptive drugs for clients at every stage of life. Kotra Pharma’s prescription medicines are marketed under Axcel and Vaxcel brands that provide a line of paediatric, anti-infective and dermatological products in various dosage forms. The over-the-counter products include health and dietary supplements under the Appeton Brand. The company is headquartered in Melaka and marked its 30th anniversary in 2012.
For more information on Kotra Pharma, visit www.jediwealth.com
Corporate Communication Manager
Tel: +603 7494 0788
Please refer belows link for NPCB Industry Excellent Award Certificate.
NPCB Industry Excellent Award.jpg